Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients

Respiratory Research

Volumn 6, Issue , 2005, Pages

  Griese, Matthias ^a   Essl, Robert ^a   Schmidt, Reinhold ^b   Ballmann, Manfred ^c   Paul, Karl ^d   Rietschel, Ernst ^e   Ratjen, Felix ^f  

^a UNIVERSITY OF MUNICH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e Children's Hospital   (Germany)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Phospholipids; Pulsating bubble; Surface activity; Surfactant protein

Indexed keywords

SURFACTANT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; SURFACTANT ASSOCIATED PROTEIN;

ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; BRONCHITIS; BRONCHOSCOPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; MULTICENTER STUDY; NEUTROPHILIA; PROTEIN ANALYSIS; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; SMALL AIRWAY DISEASE; SURFACE TENSION; CHEMISTRY; COMPLICATION; CROSS-SECTIONAL STUDY; LUNG; METABOLISM; PATHOPHYSIOLOGY; PNEUMONIA; SURFACE PROPERTY;

CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUNG; MALE; PNEUMONIA; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; RESPIRATORY FUNCTION TESTS; SURFACE PROPERTIES;

EID: 27844521936     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-6-133     Document Type: Article

References (29)

1. Gibson R, Burns JL, Ramsey BW: Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Resp Crit Care Med 2003, 168: 918-951.
2. Enhorning G: Pulmonary surfactant function in alveoli and conducting airways. Can Respir J 1996, 3: 21-27.
3. Griese M: Pulmonary surfactant in health and lung diseases: state of the art. Eur Respir J 1999, 13: 1455-1476.
4. Mander A, Langton-Hewer S, Bernhard W, Warner JO, Postle AD: Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections. Am J Respir Cell Mol Biol 2002, 27: 714-721.
5. Noah T, Murphy PC, Alink JJ, Leigh MW, Hull WM, Stahlman MT et al.: Bronchoalveolar lavage fluid SP-A and SP-D are inversely related to inflammation in early cystic fibrosis. Am J Respir Crit Care Med 2003, 168: 685-691.
6. Hull J, South M, Phelan P, Grimwood K: Surfactant composition in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997, 156: 161-165.
7. Griese M, Essl R, Schmidt R, Rietschel E, Ratjen F, Ballmann M et al.: Pulmonary surfactant, lung function and endobronchial inflammation in cystic fibrosis. Am J Resp Crit Care Med 2004, 170: 1000-1005.
8. Gustafsson P, Aurora P, Lindblad A: Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 2003, 22: 972-979.
9. Landau L, Mellis C, Phelan P, Bristowe B, Mc Lennan L: Small airway disease in children: no test is the best. Thorax 1979, 34: 217-223.
10. de Jong PA, Nakano Y, Lequin MH, Mayo JR, Woods R, Pare PD et al.: Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004, 23: 93-97.
11. Robinson TE, Leung AN, Northway WH, Blankenberg FG, Chan FP, Bloch DA et al.: Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 2003, 168: 588-593.
12. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutièrrez JP, Hull J et al.: Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997, 156: 1197-1204.
13. Khan T, Wagener J, Bost T, Martinez J, Accurso F, Riches D: Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995, 151: 1075-1082.
14. Griese M, Koch N, Paul K, Rietschel E, Ballmann M, Ratjen F et al.: Biophysical activity of pulmonary surfactant in cystic fibrosis. Pediatr Pulmonol 2000, 30: 297.
15. Ratjen F, Rietschel E, Griese M, Ballmann M, Kleinau I, Döring G et al.: Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Eur Respir J 2000, 15: 141-145.
16. Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J et al.: Effect of treatment with dornase alpha on airway inflammation in cystic fibrosis patients. Am J Respir Crit Care Med 2004, 169: 719-725.
17. Griese M, Maderlechner N, Ahrens P, Kitz R: Surfactant proteins A and D in children with pulmonary disease due to gastroesophageal reflux. Am J Resp Crit Care Med 2002, 165: 1546-1550.
18. Schmidt R, Steinhilber W, Ruppert C, Grimminger F, Seeger W, Günther A: An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 2002, 165: 470-474.
19. Griese M, Birrer P, Demirsoy A: Pulmonary surfactant in cystic fibrosis. Eur Respir J 1997, 10: 1983-1988.
20. Enhorning G, Holm BA: Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. J Appl Physiol 1993, 74: 2922-2927.
21. von Bredow C, Birrer P, Griese M: Surfactant protein A and other bronchoalveolar lavage proteins are altered in cystic fibrosis. Eur Respir J 2001, 17: 716-722.
22. Griese M, Wiesener A, Lottspeich F, v.Bredow C: Limited proteolysis of surfactant protein D causes a loss of its calcium-dependent lectin functions. Biochim Biophys Acta 2003, 1638: 157-163.
23. Postle AD, Mander A, Reid KM, Wang JY, Wright S, Moustaki M et al.: Deficient hydrophilic lung surfactant proteins A und D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Resp Cell Mol Biol 1999, 20: 90-98.
24. Hirche TO, Crouch EC, Espinola M, Brokelman TJ, Mecham RP, DeSilva N et al.: Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain. J Biol Chem 2004, 279: 27688-27698.
25. Malloy JL, Veldhuizen RA, Thibodeaux BA, O'callaghan RJ, Wright JR: Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am J Physiol Lung Cell Mol Physiol 2004.
26. Seeger W, Grube C, Günther A, Schmidt R: Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993, 6: 971-977.
27. Macklem PT, Proctor DF, Hogg JC: The stability of peripheral airways. Respir Physiol 1970, 8: 191-203.
28. Griese M, Bufler P, Teller J, Reinhardt D: Nebulization of a bovine surfactant in cystic fibrosis: a pilot study. Eur Respir J 1997, 10: 1989-1997.
29. Griese M, Felber J, Reiter K, Strong P, Reid K, Belohradsky BH et al.: Airway inflammation in children with tracheostomy. Pediatr Pulmonol 2004, 37: 356-361.